14 Einträge gefunden

1. Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer:an international pooled analysis of individual patient data from four prospective observational studies

   1. Yamamoto, Yutaka
   2. Yamashiro, Hiroyasu
   3. Schneeweiss, Andreas
   4. Müller, Volkmar
   5. Gluz, Oleg
   6. Klare, Peter
   7. Aktas, Bahriye

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer

   1. Nitz, Ulrike A
   2. Gluz, Oleg
   3. Kümmel, Sherko
   4. Christgen, Matthias
   5. Braun, Michael
   6. Aktas, Bahriye
   7. Lüdtke-Heckenkamp, Kerstin

   2022 - Forschungsinformationssystem des UKE
3. Update Breast Cancer 2021 Part 1 - Prevention and Early Stages

   1. Stickeler, Elmar
   2. Aktas, Bahriye
   3. Behrens, Annika
   4. Belleville, Erik
   5. Ditsch, Nina
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Witzel, Isabell
   3. Aktas, Bahriye
   4. Fasching, Peter A
   5. Hartkopf, Andreas
   6. Janni, Wolfgang
   7. Kasimir-Bauer, Sabine

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
5. Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Fehm, Tanja
   3. Janni, Wolfgang
   4. Aktas, Bahriye
   5. Fasching, Peter A
   6. Kasimir-Bauer, Sabine
   7. Milde-Langosch, Karin

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
6. The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Witzel, Isabell
   3. Riethdorf, Sabine
   4. Pantel, Klaus
   5. Rack, Brigitte
   6. Janni, Wolfgang
   7. Fasching, Peter A

   2018 - Forschungsinformationssystem des UKE
7. Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients

   1. Banys-Paluchowski, Malgorzata
   2. Witzel, Isabell
   3. Riethdorf, Sabine
   4. Rack, Brigitte
   5. Janni, Wolfgang
   6. Fasching, Peter Andreas
   7. Solomayer, Erich-Franz

   2017 - Forschungsinformationssystem des UKE
8. Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Witzel, Isabell
   3. Riethdorf, Sabine
   4. Rack, Brigitte
   5. Janni, Wolfgang
   6. Fasching, Peter A
   7. Solomayer, Erich-Franz

   2017 - Forschungsinformationssystem des UKE - frei zugänglich
9. Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients

   1. Aktas, Bahriye
   2. Kasimir-Bauer, Sabine
   3. Müller, Volkmar
   4. Janni, Wolfgang
   5. Fehm, Tanja
   6. Wallwiener, Diethelm
   7. Pantel, Klaus

   2016 - Forschungsinformationssystem des UKE - frei zugänglich
10. The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer.

    1. Wallwiener, Markus
    2. Hartkopf, Andreas Daniel
    3. Baccelli, Irène
    4. Riethdorf, Sabine
    5. Schott, Sarah
    6. Pantel, Klaus
    7. Marmé, Frederik

    2013 - Forschungsinformationssystem des UKE
11. Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study.

    1. Müller, Volkmar
    2. Riethdorf, Sabine
    3. Rack, Brigitte
    4. Janni, Wolfgang
    5. Fasching, Peter A
    6. Solomayer, Erich
    7. Aktas, Bahriye

    2012 - Forschungsinformationssystem des UKE - frei zugänglich
12. Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.

    1. Aktas, Bahriye
    2. Müller, Volkmar
    3. Tewes, Mitra
    4. Zeitz, Julia
    5. Kasimir-Bauer, Sabine
    6. Loehberg, Christian R
    7. Rack, Brigitte

    2011 - Forschungsinformationssystem des UKE
13. Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.

    1. Müller, Volkmar
    2. Riethdorf, Sabine
    3. Rack, Brigitte
    4. Janni, Wolfgang
    5. Fasching, Peter A
    6. Solomayer, Erich
    7. Aktas, Bahriye

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
14. HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

    1. Fehm, Tanja
    2. Müller, Volkmar
    3. Aktas, Bahriye
    4. Janni, Wolfgang
    5. Schneeweiss, Andreas
    6. Stickeler, Elmar
    7. Lattrich, Claus

    2010 - Forschungsinformationssystem des UKE